throbber
JANSSEN EXHIBIT 2058
`
`Mylan v. Janssen IPR2016-01332
`
`JANSSEN EXHIBIT 2058
`Mylan v. Janssen IPR2016-01332
`
`

`

`The Adrenal
`
`Gland
`
`INTRODUCTION 540
`
`’
`
`SYSTEM FUNCTION: THE ADRENAL
`MEDULLA 549
`
`540
`
`The Synthesis, Storage, and Release of
`
`Catecholamines 549
`
`SYSTEM FUNCTION: THE ADRENAL
`
`Catecholamine Actions and
`
`CORTEX 540
`
`Regulation 550
`
`“R” 3"“ ACT" 5“
`Cortical Hormones: Their Actions and
`
`PATHOPHYSIOLOGY: MEDULLARY
`DYSFUNCTION 551
`
`Regulatm" 542
`Stermd B'°synthes'S 545
`PATHOPHYSIOLOGY: DISEASES OF
`CORTICAL OVER- AND
`UNDERPRODUCTION 545
`
`Diseases of Overproduction 545
`
`Diseases of Underproduction 548
`
`Catecholamine Overproduction 551
`Catecholamine Underproduction 551
`
`

`

`inferior phrenic artery
`
`Superior adrenal
`artery
`
`Middle adrenal
`artery
`
`
`
`Subcapsular plexus
`
`inferior adrenal
`artery
`
`Kidney
`
`Figure 34.1 Arterial supply to the adrenal glands. The adrenal
`arteries are not drawn to scale, nor drawn in their exact anatomic
`locations.
`
`testicular and ovarian veins. The left testicular/
`ovarian vein drains into the left renal vein, while the
`right testicular/ovarian drains right into the IVC.
`The medulla and cortex of the adrenal glands
`are separate in structure, function, and embryologic
`origin. The cortex arises from the mesoderm, while
`the medulla derives from the ectoderm. The meso-
`
`dermal gonadal ridge gives rise to the steroidogenic
`cells of the ovaries and testes as well as the adrenal
`
`cortex precursor cells, which migrate to the
`retroperitoneum. These mesodermal cortical cells
`are invaded by migrating ectodermal neural crest
`cells, which will become the medulla. Encapsulation
`of the adrenal gland around week 8 of fetal life
`creates a unified organ out of these two originally
`separate entities.
`
`SYSTEM FUNCTION: THE ADRENAL
`CORTEX
`
`The adrenal cortex makes up 80% to 90% of the
`adrenal gland by volume and comprises three histo-
`logically and functionally distinct zones, each of
`which makes a different steroid (FIGURE 34.3). Starting
`from the outermost,
`these layers are the zona
`glomerulosa, which produces aldosterone;
`the
`zona fasciculata, which produces cortisol; and the
`zona reticularis, which produces adrenal androgens,
`primarily DHEA (dehydroepiandrosterone) and
`androstenedione. (Some cortisol is produced in the
`zona reticularis.)
`1
`
`540
`
`l"E3i‘: will Endocrine Physiology
`
`INTRODUCTION
`
`The adrenal gland plays a pivotal role in human
`endocrine physiology. Although considered one
`gland anatomically, the adrenal gland functions as
`two distinct entities: the cortex and the medulla.
`
`These two portions of the adrenal originate from
`different embryonic tissues and have distinctly
`different physiologic roles.
`The outermost shell of the adrenal gland, the
`adrenal cortex, produces three kinds of steroid
`hormones: aldosterone, cortisol, and androgens.
`Aldosterone, a mineralocorticoid, modulates elec-
`
`trolyte and fluid balance by stimulating sodium re-
`tention in the kidney’s collecting ducts. Cortisol, a
`glucocorticoid, plays a crucial role in the body’s
`stress response, in the regulation of protein, glucose,
`and fat metabolism, in the maintenance of vascular
`tone, and in the modulation of inflammation. The
`
`adrenal androgens are most important during fetal
`life as a substrate for placental estrogen production,
`but they play a minor role during adult life. The
`adrenal medulla is the inner core of the adrenal
`
`gland; it produces the catecholamines epinephrine
`and norepinephrine, which are also important
`components of the stress response.
`Adrenal function is essential to human life.
`
`Adrenalectomy will lead to cardiovascular collapse
`and death within a few days from a lack of cortisol,
`which maintains blood vessel
`tone and blood
`pressure.
`
`SYSTEM STRUCTURE: ADRENAL
`ANATOMY AND EMBRYOLOGY
`
`The adrenals are triangular retroperitoneal or-
`gans located at the superior poles of the kidneys,
`lateral to the 11th thoracic and 1st lumbar verte-
`
`brae. These glands receive blood from the superior
`adrenal artery, a branch of the inferior phrenic; the
`middle adrenal artery, a branch of the aorta; and the
`inferior adrenal artery, a branch of the renal artery
`(FIGURE 34.1). This rich blood supply from three
`distinct locations explains why the adrenals are a
`frequent site of metastases from distant primary
`cancers. More importantly, the rich blood supply
`ensures the adrenals access to the bloodstream to
`facilitate hormonal secretion. The adrenal arteries
`
`anastomose (network) into a subcapsular plexus,
`which in turn branches into arteries that
`flow
`
`these arteries form capillary
`inward. Some of
`networks in the cortex and some form capillary
`networks in the medulla (FIGURE 34.2). The left
`adrenal vein drains into the left renal vein, while the
`right adrenal vein drains directly into the inferior
`vena cava (IVC). This drainage is analogous to the
`
`

`

`
`
`
`3
`‘g
`0
`
`................
`EO.)
`E
`
`\
`\
`
`5‘. "
`l
`ll
`
`\\
`
`‘V
`‘I
`
`l_
`
`~-
`
`Medullary
`capillaries
`’ __
`W.
`
`34 The Adrenal Gland
`
`541
`
`capillaries
`
`Medullary
`artery
`
`......................
`
`Cortical
`
`vein
`Medullary
`vein
`~
`
`~
`J
`
`’
`
`.
`
`'
`
`..
`
`Central vein
`
`Figure 34.2 Vasculature inside the adrenal glands. The subcapsular plexus gives rise
`to arteries that form medullary capillary beds and to arteries that form cortical capillary
`beds.
`
`CRH and ACTH
`
`Production of the steroids in the adrenal cortex
`
`is regulated by the hypothalamic-pituitary-adrenal
`(HPA) axis (FIGURE 34.4). At the top of the HPA axis,
`the hypothalamus releases corticotropin-releasing
`hormone (CRH), which stimulates the anterior pitu-
`
`itary to release pro—opz'omelanocortin, a precursor
`molecule that is cleaved into four main products:
`melanocyte-stimulating hormone, beta-lipotropins,
`beta—endorphins, and adrenocorticotropic hormone
`(ACTH). ACTH, also known as corticotropin,
`is
`released into the bloodstream and acts in the cortex,
`
`stimulating the synthesis and release of over 50
`
` airanVIaruiié
`
`iv;I,,5!.!.§}/t
`«IIIIVP-1'M
`
`
`3=h
`
`vs‘
`FA‘
`3'.lafi
`
`ilk, *
`
`2
`
`Figure 34.3 Adrenal zonation.
`
`> Capsule
`
`-——:> Mineralocorticoids
`Zona
`glomerulosa
`
`> Cortex
`
`Zona -e> Glucocorticoids
`> fasciculata
`
`Zona
`_ -—-----> Androgens
`_
`reticularis
`J
`
`
`
`"FA/'
`
`llflIF]!
`
`'1
`:3K
`
`

`

`542
`
`Part VIII Endocrine Physiology
`
`Circadian
`rhythm
`A
`Su rachiasmatic
`pnucleus
`
`Stress
`inputs
`
`.
`Hippocampus 0
`
`Hypothalamus\ Q‘
`
`fg
`
`, CFIH and/or AVP
`
`G
`
`
`
`Shortfeedback
`
`
`
`xoeqpeei5uo'1
`
`Free cortisol
`
`
`
`Figure 34.4 Hypothalamic—pituitary—adrenal axis. Stress, circa-
`dian rhythms, and negative feedback from cortisol all influence the
`paraventricular nucleus ofthe hypothalamus and modulate CRH out-
`put. Stressors may be organic in nature [such as hypoglycemia or in-
`fection] or psychological.
`
`steroid products, the most important of which are
`cortisol, the adrenal androgens, and aldosterone,
`although aldosterone is largely regulated in direct
`response to serum potassium levels and by an-
`giotensin II, a hormone that helps to regulate blood
`pressure. In a classic endocrine feedback loop, corti-
`sol directly inhibits both CRH production at the
`hypothalamic level and ACTH at the pituitary level,
`thereby acting as the main control mechanism for all
`adrenal cortical hormone production, with the
`exception of aldosterone.
`
`The cortex responds dramatically to stimulation
`from ACTH, which elevates steroid production within
`minutes. It does so by activating a receptor on the
`cortical cell membranes that is linked to a G protein
`(FIGURE 34.5). The G protein, in turn, activates adeny-
`lyl cyclase and raises the cAMP level, activating a
`protein kinase. The kinase phosphorylates and hence
`
`ACTH
`
` _
`
`.
`
`\ Mitochonrion
`
`A
`Protein
`kmase A
`
`\\
`
`If
`1 1—Deoxy\-\%',>_ Cortisol,‘
`cortisol
`\
`_l
`\\
`\~ \ \\
`\
`x
`.
`_\
`,‘
`\
`CE
`\
`17-OH ‘<.?'—Preg <—4— Cholesterol T—’C“°‘e5‘°'Y'
`
`H
`
`meg
`
`Smooth i~:Rl
`l‘
`"
`l
`
`\)
`
`I
`'/
`
`l
`
`/
`Lipid droplet
`
`esters
`
`Figure 34.5 Action of ACTH on the adrenal cortex. AC, adenylyl
`cyclase; CEH, cholesteryl ester hydrolase; G, G protein (linking the
`receptor to the adenylyl cyclase]; LDL, low—density lipoprotein; Preg,
`pregnenolone [cortisol precursor); R, ACTH receptor; Smooth ER,
`smooth endoplasmic reticulum.
`
`activates the enzyme cholesteryl ester hydrolase
`(CEH), which promotes the conversion of cholesteryl
`esters into free cholesterol. The free cholesterol
`
`then supplies the steroid synthesis pathways, as
`described below. Chronic stimulation with excessive
`
`ACTH causes bilateral adrenal hypertrophy, while
`removal or destruction of the pituitary, which is
`responsible for producing ACTH, conversely leads to
`adrenal atrophy.
`
`Cortical Hormones: Their Actions and
`Regulation
`
`As steroids, the cortical hormones all share
`
`certain functional features. They are all secreted into
`the adrenal blood vessels and circulate from the
`
`adrenal veins to target tissues all over the body. At
`the target tissues, they dissolve into the lipid mem-
`branes of the tissues and pass into the intracellular
`cytosol. There, the steroids bind cytosolic receptor
`proteins, which in turn bind to particular DNA
`sequences, thereby initiating the transcription of
`mRNA, resulting in the synthesis of new proteins.
`As mentioned above and described in more
`detail below, the secretion of steroid hormones from
`
`the cortex is regulated by various kinds of negative-
`feedback loops. TABLE 34.1 summarizes the actions of
`the cortical steroids.
`
`

`

`34 The Adrenal Gland
`
`543
`
`
`
`Table 34.1 ACTIONS OF THE CORTICAL STEROIDS
`
`Main Actions
`Adrenal Hormone
`
`Aldosterone
`
`Cortisol
`
`- Increases salt and water reabsorption from kidney tubules
`- Increases K+ secretion in kidneys
`
`- Counterregulatory effects: increases blood sugar, increases
`catabolism of triglyceride and protein
`- Anti—inflammatory/immunosuppressant effects
`- Maintains blood vessel tone and hence blood pressure
`
`- Help determine male sex characteristics during fetal
`Androgens
`development and puberty
`
`Aldosterone Action Aldosterone plays a key role in
`the regulation of fluid balance by enhancing the abil-
`ity of kidney tubules to absorb salt and water in two
`ways. First, aldosterone directly stimulates the
`production and activity of Na+/K+—ATPase pumps
`located in the basolateral side of the cortical col-
`
`lecting ducts. These pumps exchange sodium for
`potassium, and aldosterone stimulation of these
`pumps leads to increased sodium reabsorption in
`exchange for potassium excretion. Remember that
`increased reabsorption of sodium leads to passive
`water reabsorption and increased extracellular fluid
`volume (see Chapter 22).
`Second, aldosterone increases salt and water
`reabsorption in the kidney by creating more apical
`Na+ channels, directly increasing sodium permeabil-
`ity on the luminal side of the cortical collecting ducts.
`Aldosterone also drives K+ secretion through its
`effects on the translocation of Na+. Increased Na+ re-
`absorption creates tubular electronegativity and
`drives paracellular K+ secretion (see Chapter 24).
`‘
`Finally, aldosterone acts on the HT-ATPase in the
`renal tubule and has other effects on acid-base bal-
`
`ance (see Chapter 25). Because it acts on the levels of
`these inorganic (mineral) electrolytes, it is termed a
`mineralocorticoid.
`
`Aldosterone Regulation Aldosterone regulation is
`unique in that it is the only adrenal cortical hormone
`that is secreted largely independently of ACTH. A
`small amount of ACTH from the pituitary is required
`for aldosterone release, but aldosterone is regulated
`mainly by two other control mechanisms: the serum
`potassium level and the renin—angiotensin-aldos-
`terone (RAA) system. Elevated potassium levels trig-
`ger aldosterone secretion, which in turn stimulates
`renal potassium excretion Via the Na+/K+ exchange
`pump to rectify the hyperkalemia. Low blood pres-
`sure stimulates the adrenal to secrete aldosterone
`
`through the RAA system. This increases salt reab-
`sorption and raises the extracellular fluid volume and
`blood pressure.
`
`Cortisol Action Cortisol has a multitude of actions,
`
`and derivatives of this hormone are used frequently
`in medical therapy. Cortisol is consequently one of
`the most challenging adrenal hormones to under-
`stand and at the same time one of the most clinically
`relevant. Cortisol is produced mostly by the fasci-
`culata, with some production in the reticularis.
`Although mainly exerting glucocorticoid activity (ex-
`plained below), cortisol also functions as a weak
`mineralocorticoid, with effects similar to those of al-
`dosterone. Cortisol’s precursor, corticosterone, also
`exhibits some glucocorticoid activity. About 20 to 30
`mg of cortisol is secreted per day by the adrenals,
`with 90% to 95% of circulating cortisol bound in the
`
`plasma to cortisol-binding globulin.
`Glucocorticoid action can be thought of mainly in
`two broad categories: metabolic and anti—inflamma—
`tory. Although the myriad metabolic actions of
`cortisol can be daunting, it is useful to remember that
`cortisol acts to prepare the body for stress. Teleologi-
`cally speaking, in times of stress the body does not
`have the energy surplus to build protein or add to
`triglyceride and glycogen stores; instead it requires
`rapidly usable energy for the brain in the form of glu-
`cose. Therefore, the body under stress will mobilize
`amino acids and fatty acids as substrates for gluco-
`neogenesis (see Chapter 31). Under glucocorticoid in-
`fluence, an increase in all gluconeogenic enzymes
`raises hepatic gluconeogenesis sixfold. Blood sugar
`levels climb, while peripheral uptake and utilization of
`glucose are decreased. To fuel this upregulated gluco-
`neogenic activity, cortisol increases the production of
`amino acids from muscle breakdown. Synthesis of
`protein and fat is halted, as the main focus is on
`survival and the mobilization of stores (catabolism)
`rather than on growth and repair (anabolism).
`This bolus of glucose is liberated from tissue
`energy stores instead of from the diet. Thus, gluco-
`corticoids are counrerregulatory hormones, alongside
`glucagon, epinephrine, and growth hormone. Gluco-
`corticoids reproduce glucagon action and oppose
`insulin action. However, glucocorticoids do not
`
`

`

`544
`
`Part VIII Endocrine Physiology
`
`
`
`The Insulin/Counterregulatory Balance
`
`
`
`The stress response induced by cortisol is intended to be only temporary. If
`exposure to cortisol is prolonged, as in long-term treatment with prednisone (a
`glucocorticoid administered as medicine), the body suffers deleterious effects. A
`constant elevation of cortisol levels disrupts the normal balance between insulin
`and cortisol, leaving the body in a prolonged state of catabolism, which can be very
`destructive.
`
`In Cushing’s disease, excess ACTH production leads to an abnormal elevation
`of cortisol and disruption of the metabolic balance. Skin striae, skin thinning, and
`muscle weakness ensue from excessive protein and collagen breakdown due to
`cortisol action. In diabetes mellitus, low insulin production disrupts the balance
`between cortisol and insulin. When diabetics experience physical stress such as
`illness or infection, cortisol levels increase and blood sugar levels increase, and
`therefore their insulin requirement goes up.
`
`
`
`
`promote glycogen breakdown as does glucagon. This
`phenomenon is known as glucocorticoid’s glycostatic
`effect. (See Integrated Physiology Box The Insulin/
`Counterregulatory Balance.)
`Cortisol also has powerful effects on the immune
`system, which accounts for the widespread use of
`glucocorticoids as anti-inflammatories and as im-
`munosuppressants. Cortisol reduces the inflamma-
`
`tory response by both blocking the early stages of
`inflammation and speeding up the resolution of
`inflammation. Inflammation is decreased in a number
`
`of specific ways:
`
`0 Stabilization of white cell granules, which
`release proteolytic enzymes during
`inflammation
`
`0 Decreased capillary permeability (which
`decreases edema)
`
`- Decreased production of prostaglandins and
`leukotrienes, both of which are powerful
`stimuli of inflammation
`
`0 Decreased leukocyte migration
`
`- Decreased interleukin-1 (IL-1) and IL-6 release
`
`0 Direct suppression of T cells
`
`0 Decreased production of lymphocytes and
`antibodies
`
`Because of the powerful immunosuppressant ef-
`fects of cortisol, patients taking glucocorticoids for
`prolonged periods should be considered immuno-
`compromised and at an increased risk for infections.
`Cortisol is also a powerful modulator of the
`allergic response, acting to decrease eosinophil
`production, increase eosinophil apoptosis, and limit
`the inflammation that can be deadly in anaphylaxis.
`Interestingly, cortisol increases red blood cell pro-
`duction in an unknown manner. Finally, cortisol acts
`
`to maintain blood pressure by potentiating cate-
`cholamines and by directly supporting blood vessel
`tone.
`
`Cortisol Regulation Cortisol is regulated by the HPA
`axis, as mentioned above. The median eminence of the
`
`hypothalamus is responsible for the production of
`CRH, which is produced in response to a host of stress-
`ful stimuli: trauma, infection, catecholamines, surgery,
`and so on. How the hypothalamus detects these stim-
`uli has not been completely worked out. CRH is also re-
`leased in a circadian manner, leading to a diurnal vari-
`ation with cortisol levels peaking in the early morning.
`CRH triggers ACTH release from the anterior pituitary.
`ACTH is also modulated by antidiuretic hormone
`(ADH), which acts synergistically with CRH to stimu-
`late ACTH release. Cortisol is almost exclusively regu-
`lated by ACTH, which activates cholesteryl ester hy-
`drolase (CEH) and ultimately increases the production
`of pregnenolone, a cortisol precursor. Cortisol inhibits
`CRH and ACTH in a classic negative-feedback loop.
`
`The Androgens The adrenal androgens, like the
`gonadal androgens, are male sex hormones—that is,
`they help determine and maintain male sex charac-
`teristics. The principal adrenal_androgens are an-
`drostenedione, dehydroepiandrosterone (DHEA),
`and DHEA-S. These hormones have a negligible effect
`on adult physiology compared to the gonadally
`produced hormones (such as testosterone), which
`account for the majority of sex hormone effects. They
`are about one fifth as potent as testosterone.
`Androstenedione can be converted to testosterone,
`which is in turn converted to dihydrotestosterone
`(DHT) and estradiol in extra-adrenal tissues. These
`androgens are most important during fetal develop-
`ment and puberty.
`
`

`

`In the fetus, the adrenal glands are much larger
`proportionally than in the adult, and a layer known as
`the provisional or fetal cortex exists, which is analo-
`gous to the adult reticularis. This layer produces
`DHEA-S, which is converted by the placenta into an-
`drogens and estrogens. Overproduction of DHEA—S,
`as in congenital adrenal hyperplasia (discussed
`below), can lead to fetal virilization in female infants.
`Adrenal androgens are also important during
`adolescence, when they stimulate the development
`of pubic and axillary hair in women, which is know as
`adrenarche. Adrenarche and puberty normally coin—
`cide, but they are actually two physiologically sepa-
`rate events. Androgen production continues into
`adulthood and declines with age. Androgens con-
`tinue to cause groin and axillary hair growth in adult
`. women. Many claims have been made about DHEA as
`a “youth hormone,” but at this point, there is little sci-
`entific evidence for the efficacy of DHEA replacement
`as a fountain of youth.
`
`Steroid Biosynthesis
`
`All the products of the adrenal cortex are steroid
`hormones, which have a standard four—ring structure
`and are produced by a similar biosynthetic pathway.
`Enzymes specific to each layer of the cortex influence
`the structural differences of the hormones produced.
`Cholesterol provides the basic four—ring steroid
`framework. Although the adrenals can synthesize
`cholesterol de novo from acetyl CoA, 80% of the
`cholesterol used in adrenal hormone synthesis comes
`from dietary cholesterol packaged as cholesteryl
`ester in circulating low-density lipoprotein (LDL) par-
`ticles. CEH converts the esters to free cholesterol in
`
`response to ACTH. The rate—limiting step in hormone
`biosynthesis is the transfer of cholesterol to the inner
`mitochondrial membrane of adrenal cells via the
`
`steroidogenic acute regulatory protein (SIAR), followed
`by the conversion of cholesterol to pregnenolone.
`This reaction is catalyzed by the enzyme desmolase.
`Once pregnenolone is made from cholesterol,
`the pregnenolone flows downhill through each zone
`of the cortex, undergoing successive modifications to
`the basic steroid ring. These modifications result in a
`distribution of various steroid products throughout
`the adrenal cortex (FIGURE 34.6). The steroids are re-
`leased immediately after synthesis; very little of the
`cortical hormones are stored. This is in direct con-
`
`trast to the medulla, which packages and stores its
`products for release under stimulus at a later time.
`Some enzymes in the steroid biosynthetic path-
`ways are common to all three zones, while others are
`unique to a specific adrenal zone. Pregnenolone
`flows across zones and also undergoes progressive
`transformation along each zone’s unique enzymatic
`
`34 The Adrenal Gland
`
`545
`
`pathway unless an enzyme deficiency in one pathway
`acts as a roadblock. Such a condition prevents fur-
`ther modification of the steroid product, leading to
`an excess of premodification substrate that will spill
`over into the remaining open routes. An example of
`this hormonal roadblock is found in the pathologic
`condition congenital adrenal hyperplasia (CAH).
`(See Clinical Application Box What Is Congenital
`Adrenal Hyperplasia?)
`
`PATHOPHYSIOLOGY: DISEASES
`OF CORTICAL OVER— AND
`UNDERPRODUCTION
`
`Levels of cortisol and aldosterone normally vary
`in response to changing conditions in the body. Dur~ '
`ing stress, cortisol levels rise. When blood pressure
`is low, aldosterone levels rise. Pathologic conditions,
`however, may interfere with the adrenal cortex’s
`normal response to stimuli. These conditions are
`classified as those that cause the overproduction of a
`hormone and those that cause underproduction. in
`cases of overproduction, the hormone is secreted at
`levels out of proportion to adrenal stimuli. In cases of
`underproduction, the adrenal cortex cannot mount
`the normal response to stimuli.
`
`Diseases of Overproduction
`
`Diseases of overproduction may be primary to
`the adrenal gland, or they may originate outside the
`adrenal (in which case hyperproduction is called
`secondary). For example, ACTH overproduction in
`the pituitary can stimulate a perfectly normal adrenal
`gland to overproduce cortisol. Chronic stimulation of
`the RAA system due to renal disease can cause a nor-
`mal adrenal to overproduce aldosterone. Isolated
`overproduction of androgens is much less common
`and usually arises from CAH and less commonly from
`adrenal carcinomas or adenomas.
`
`Hypercortisolism Excess glucocorticoid exposure,
`called hypercortisolism, can lead to a variety of
`disease manifestations and is one of the most serious
`
`adrenal derangements. Excess glucocorticoids may be
`the result of endogenous overproduction or exogenous
`administration of glucocorticoid drugs in higher—than—
`normal amounts. Endogenous cortisol overproduction
`can be classified into two categories: ACTH—dependent
`and ACTH—independent. ACTH—dependent causes ac-
`count for 85% of endogenous hypercortisolism and in-
`clude Cushing’s disease (also known as pituitary ade-
`noma), ectopic ACTH production (as occurs with some
`lung cancers), and ectopic CRH production, which is
`rare. ACTH—independent causes are primary to the
`adrenal gland. They include adrenal adenoma and
`adrenocortical carcinoma. Exogenous glucocorti-
`
`

`

`546
`
`Part VIII Endocrine Physiology
`
`CH3
`1
`HC — CH2-- CH2— CH2— cH
`
`CH3
`
`
`
`H0
`
`Cholesterol
`
`/
`\
`
`CH3
`
`CH3
`
`C/"’l5’°’,""/ d9s’"°’“5e ------------------‘
`( CYP] IA )
`V
`
`I 7('1.-/1y(lro.\‘ylc1.s'e
`
`(CYP1 7)
`
`1 7,2!)-lyuse
`
`Pregnenolone
`
`l7—hydroXypregnenolone
`
`Dehydroepiandrosterone (DHEA)
`
` .313-/Iyclroxysieroid
`
`
`cle/zydrogenuse
`
`21-/wt/r<»:vIa»~e
`(CYP21)
`
`'
`
`..........................................
`v
`Progesterone
`.......................................
`'
`'
`V
`Deoxycorticosterone
`
`V
`17-hydroxypregesterone
`...........................
`V
`
`V
`
`Androstenedione
`
`
`
`I 715-/1y(lrox_v.s‘lero id
`(Ie/Iyrlrogeriase
`
`_ Testosterone
`
`terone
`
`_ . _
`
`A ‘
`
`>
`
`' V
`
`’ . H
`
`. M
`
`1 I [3-/zyc/2'()xy/rzse
`( C YPI IB I )
`
`----------- --
`
`.’)'o.-re(Iucl¢1.s‘e
`
`V s
`
`I I [3-/1ydro.x‘yl(1.s'e
`(CYPI 1132)
`
`I<8’-lzydr0.\ylase
`(CYP/1B2)
`
`................... __
`V
`
`Hydroxycorticosterone
`
`I 8—0xidase
`(CYPI 1 B2)
`
`
`
`V
`
`cH2oH
`I
`0
`H Hc = 0
`CH
`
`Ho
`
`CH3
`
`V
`
`cH2oH
`l
`o
`H HC = 0
`CH __OH
`
`Ho
`
`CH3
`
`0
`
`0
`
`Aldosterone
`
`Cortisol
`
`Zona glomerulosa
`
`Zona fasciculata
`
`OH
`
`CH3
`
`CH3
`
`0
`
`Dihydrotestosterone
`
`Zona reticularis
`
`Figure 34.6 Steroid biosynthesis. The line next to 2i—hydroxylase is highlighted to indicate the barrier to
`aldosterone and cortisol synthesis posed by 2i—hydroxylase deficiency. Such a barrier causes progesterone
`and i7—hydro><yprogesterone to build up, which decreases the rate of conversion of pregnenoione to
`progesterone and of i7—hydroxypregnenolone to i7—hydro><yprogesterone.
`in turn, pregnenolone and 17-
`hydroxypregnenolone build up and drive increased DHEA formation.
`
`coids—drug preparations like prednisone or large
`quantities of steroid inhalers—can also lead to hyper-
`cortisolism. Rarely, hypercortisolism is caused by ex-
`cess secretion of CRH from the hypothalamus.
`Hypercortisolism due to any cause yields a con-
`stellation of clinical findings known as Cushing syn-
`drome (as opposed to Cushing’s disease, which is
`one of many causes of Cushing syndrome). The signs
`and symptoms of cortisol excess, first described by
`
`Harvey Cushing in 1932, include truncal obesity, a
`round and full face (“moon facies”), a “buffalo hump”
`of fat on the posterior neck, pigmented skin striae,
`thinned skin and easy bruising, muscle weakness, os-
`teoporosis, hypertension, and hyperglycemia. The
`catabolic effects of cortisol cause muscle weakness,
`osteoporosis, striae, bruising, and hyperglycemia.
`The abnormal fat distribution is believed to be due to
`increased lipolysis, which affects the extremities
`
`

`

`34 The Adrenal Gland
`
`547
`
`more than the trunk, but a clear explanation for the
`moon facies and buffalo hump has yet to be found.
`Virilizing symptoms of hirsutism and acne can
`accompany ACTH-dependent hypercortisolism as a
`result of androgen overproduction from excessive
`ACTH. Hyperpigmentation is also seen with elevated
`ACTH levels and is believed to be caused by ACTH
`cross—reacting with melanocyte-stimulating hormone
`(MSH)
`receptors on melanin-producing cells.
`(See Clinical Application Box Diagnosing Cashing
`Syndrome with Lab Tests.)
`
`Hyperaldosteronism As with hypercortisolism,
`hyperaldosteronism can be classified into two
`categories: primary (arising from the adrenal) and
`secondary (extra-adrenal). Primary hyperaldostero-
`nism, known as Conn ’s syndrome, arises most often
`from an aldosterone—producing adrenal adenoma. Hy-
`pokalemia, hypernatremia, diastolic hypertension,
`polyuria, and muscle weakness (secondary to low
`potassium levels) are characteristics of hyperaldos-
`teronism. Plasma renin levels are low owing to the
`negative feedback from elevated aldosterone levels.
`
`
`
`'i.i::CL|N|CAL
`APPLICATION
`
`
`
`WHAT IS CONGENITAL ADRENAL HYPERPLASIA?
`
`A newborn girl in the hospital nursery is discovered to have abnormal findings on
`examination of her genitals. She has an enlarged clitoris and a single urogenital sinus
`instead of separate openings for the vagina and urethra. She also has low blood
`pressure and a high plasma K+ level. With a putative diagnosis of congenital adrenal
`hyperplasia, the infant receives hydrocortisone and fludrocortisone (a medicinal
`mineralocorticoid) and is placed on daily salt supplements. The family is referred to
`a surgeon and a psychiatrist for consultation.
`Patients with congenital adrenal hyperplasia (CAH) have a genetic deficiency of
`2]—hydroxylase, an enzyme that transforms progesterone to corticosterone in the
`glomerulosa and transforms 17-hydroxyprogesterone to cortisol in the fasciculata.
`When this enzyme is absent, the aldosterone and cortisol precursors encounter a
`“block” and accumulate. Encountering this backup, progesterone and 17-hydroxy
`progesterone can overflow into the androgen biosynthetic pathway, where they are
`converted by 17, 20—lyase into DHEA and androstenedione, creating a surplus of
`androgenizing hormones (and a deficiency of aldosterone and cortisol, which cannot
`be made without 21-hydroxylase). Because of the lack of cortisol, which normally
`provides negative feedback to the brain, the hypothalamus and pituitary continue to
`churn out CRH and ACTH to make up for the cortisol deficit, leading to adrenal
`hypertrophy and even more pregnenolone production.
`Excess pregnenolone in the context of 2l—hydroxylase deficiency results in more
`DHEA production. Normally, DHEA has only a minor effect on females, as a stimulus
`for pubic and axillary hair growth and as a substrate for testosterone production.
`However, in female fetuses undergoing sexual differentiation, large amounts of DHEA
`result in clinically significant levels of testosterone, which in turn can lead to virilized
`external genitalia. At birth, female infants with CAH may be mistaken for male or may
`have what is known as ambiguous genitalia. Male infants with CAH initially may go un-
`diagnosed as they do not have ambiguous genitalia. (They are exposed to virilizing
`testosterone in utero as part of normal genital development.)
`A lack of cortisol and aldosterone can be disastrous for both male and female
`
`infants. Aldosterone deficiency in many cases leads to a salt—wasting crisis with
`profound hyponatremia, hyperkalemia, hypotension, and acidosis. Lack of cortisol
`impairs carbohydrate metabolism and can lead to death from loss of blood vessel
`tone and blood pressure normally maintained by cortisol.
`Glucocorticoid administration makes up for cortisol deficiency and suppresses
`
`ACTH, thereby decreasing excess pregnenolone and hence androgen production.
`Mineralocorticoid and salt administration counteract the salt wasting due to
`aldosterone deficiency, which is present in the majority of cases. Now that the genetic
`basis of CAH has been clearly elucidated, prenatal diagnosis and even treatment are
`possible.
`
`
`

`

`548
`
`Part VIII Endocrine Physiology
`
`
`
`.--;C_L|N|CAL
`
`APPLICATION
`
`
`
`DIAGNOSING CUSHING SYNDROME WITH LAB TESTS
`
`Several tests are available to help diagnose Cushing syndrome, each with varying de-
`grees of sensitivity and specificity. The first and most direct test is measurement of
`the plasma cortisol level, which is done at night. Normally, circadian rhythms dictate
`a drop in cortisol secretion during the night. However, because night-time depression
`in cortisol levels does not occur to the same extent in patients with Cushing syn-
`drome, their late—night plasma cortisol levels may be elevated. A salivary cortisol test
`has also been recently introduced to assess night-time cortisol secretion. In addition,
`because increased plasma cortisol leads to increased renal cortisol filtration and ex-
`cretion, Cushing syndrome can be detected with a 24-hour collection of urine—free
`cortisol.
`
`The dexamethasone-suppression test is used to detect ACTH-dependent causes of
`Cushing syndrome. The test entails the administration of dexamethasone, followed
`by measurement of ACTH levels. Dexamethasone is a glucocorticoid and normally
`suppresses ACTH secretion just as cortisol does. However, ACTH-secreting pituitary
`adenomas or _ectopic sources of ACTH do not respond to negative feedback normally
`but continue to secrete ACTH even in the presence of increased cortisol levels. (This,
`indeed, is the pathologic reason for the hypercortisolism in the first place.) There-
`fore, a failure to suppress the ACTH level upon dexamethasone-suppression testing
`is indicative of an ACTH-dependent cause of hypercortisolism. Imaging studies can
`then help locate the tumor that might be secreting ACTH. The sensitivity and speci-
`ficity of this test, however, are not ideal.
`
`
`Diagnosis is made by demonstrating a failure to sup-
`press aldosterone production after intravenous
`saline loading.
`The hypertension seen in primary hyperaldos—
`teronism is
`typically mild, due in part
`to the
`phenomenon of aldosterone escape (also called miner-
`alocorticoid escape). Because primary hyperaldos—
`teronism affects only one of several renal modes of
`control over the extracellular fluid volume, the kidney
`can compensate through its other modes of volume
`control. The unregulated aldosterone secretion in-
`creases salt reabsorption in the distal tubule, leading
`to increased water reabsorption and increased fluid
`volume; however, other renal mechanisms respond

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket